![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Assessment of Regional Impact on the Pharmacokinetics of VIR-2218
(BRII-835) in Participants with Chronic Hepatitis B Infection
|
|
|
AASLD 2023 nov 10-14
https://www.aasld.org/the-liver-meeting
Yali Zhu1, Sneha V. Gupta2, Chunming Li1, Chong Zhu1, Xiaofei Chen1, Weihong Liu1 and Ji Ma1
1 Brii Biosciences Limited 2 Vir Biotechnology, Inc.
![1114231](../images/111423/111423-9/1114231.gif)
![1114232](../images/111423/111423-9/1114232.gif)
![1114233](../images/111423/111423-9/1114233.gif)
![1114234](../images/111423/111423-9/1114234.gif)
![1114235](../images/111423/111423-9/1114235.gif)
![1114236](../images/111423/111423-9/1114236.gif)
![1114237](../images/111423/111423-9/1114237.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|